Eric Lefkofsky’s firm, Tempus develops, markets and delivers integrated precision medicine products through its app-centric platform that integrates medical and behavioral data to improve outcomes for cancer patients. Before Tempus, he was the co-founder and CEO of Lightbank, a high-growth Internet retailer. Prior to Lightbank, Eric Lefkofsky was Chairman and CEO of digital media company Demand Media (dmg). Eric has also served as a member of the Board of Directors for Thermo Fisher Scientific, Inc., a Fortune 500 company.
Eric Lefkofsky role in healthcare
Lefkofsky created Tempus in 2015. He became the firm’s CEO following the departure of Breg Eberts. At the age of 32, Eric Lefkofsky became the youngest business head in the pharmaceutical industry to head a drug discovery company, and one of the youngest company leaders of a publicly traded company.
Eric Lefkofksy: Our mission is to harness the power of AI to make the world more human. We want to help people and organizations see the full potential of their data and information and change the way that they interact with each other and the world.
Tempus develops a clinical technology platform to automate the analysis of electronic health records (EHRs) and blood test results to deliver better, more consistent, and personalized clinical decision support. It is led by Eric Lefkofsky.
What is the business model?
Tempus is based on artificial intelligence and machine learning to deliver clinically actionable information for medical professionals. Tempus has set a goal to eventually capture a market share of over $6 billion in US healthcare. In 2016, Eric Lefkofsky was named Forbes’ 35 Entrepreneurs Under 35, recognized by Technology Review among the most important people shaping the future of information technology.